App-Quantinova.ai

THE SEVERITY OF PULMONARY FIBROSIS IN TRANSTHORACIC ULTRASONOGRAPHY (TUS)

N. Buda - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

IDENTIFICATION OF ANTI-MYXOVIRUS RESISTANCE PROTEIN-1 AUTOANTIBODY AS A SPECIFIC MARKER FOR IDIOPATHIC NONSPECIFIC INTERSTITIAL PNEUMONIA

Y. Hamano - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Interferon

ASSOCIATION BETWEEN STEROID THERAPY AND SURVIVAL IN PATIENTS WITH RHEUMATOID ARTHRITIS INTERSTITIAL LUNG DISEASE

K. Scott - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Glucocorticoid

PULMONARY INVOLVEMENT IN CONNECTIVE TISSUE DISEASES - A RETROSPECTIVE ANALYSIS OF A MULTIDISCIPLINARY APPROACH

D. Goncalves - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Cyclophosphamide

MULTIDISCIPLINARY CONSULTATION OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH RHEUMATIC DISEASES

E. Vicens-Bernabeu - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Mycophenolic acid

RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE

M. Sebastiani - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Idiopathic pulmonary fibrosis

Methotrexate

FRAGMENT OF TYPE III COLLAGEN DEGRADATION MAY BE A NOVEL SEROLOGICAL MARKER FOR INTERSTITIAL LUNG DISEASE IN DERMATOMYOSITIS AND POLYMYOSITIS

Q. Zhao - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Idiopathic pulmonary fibrosis

N/A

INTERSTITIAL LUNG DISEASE IN PRIMARY SJOGREN SYNDROME: A GESSAR ANALISYS

S. D. Velez - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

N/A

ETIOLOGIC PROFILE OF INTERSTITIAL LUNG DISEASE IN INTERNAL MEDECINE

S. Toujani - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Cyclophosphamide

PULMONARY FIBROSIS IN ANCA-ASSOCIATED VASCULITIS: CLINICAL CHARACTERISTICS AND LONG-TERM FOLLOWUP OF 49 PATIENTS

C. Comarmond - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Cyclophosphamide

AUTOIMMUNE DISEASES ASSOCIATED WITH ANTI-KU ANTIBODIES: A RETROSPECTIVE CASE SERIES

W.A. Sifuentes Giraldo - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Methadone hydrochloride

EFFICACY OF RITUXIMAB FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASES A RETROSPECTIVE ANALYSIS

H. Jethwa - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Idiopathic pulmonary fibrosis

Cyclophosphamide

CYCLOPHOSPHAMIDE VS MYCOPHENOLATE MOFETIL IN SCLERODERMA INTERSTITIAL LUNG DISEASE (SSC-ILD) AS INDUCTION THERAPY: A SINGLE CENTER, RETROSPECTIVE ANALYSIS

M.K. Bavliya - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Idiopathic pulmonary fibrosis

Mycophenolate mofetil

CLINICAL AND IMMUNOLOGICAL FEATURES OF PATIENTS WITH ANTI-PM/SCL ANTIBODIES: A RETROSPECTIVE STUDY OF 17 CASES

W.A. Sifuentes Giraldo - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

N/A

Early Detection of Lung Involvement in Systemic Sclerosis Using Molecular Targeted Imaging

J. Schniering - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Bleomycin

Early Detection of Lung Involvement in Systemic Sclerosis Using Molecular Targeted Imaging

J. Schniering - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

Bleomycin

Inhaled Cyclosporine For The Treatment Of Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation (HSCT) Or Lung Transplantation

Nicole Gormley - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Idiopathic pulmonary fibrosis

Cyclosporine eent

HOW TO TREAT INTERSTITIAL LUNG DISEASE IN RHEUMATIC DISEASES LESSONS BEYOND CYCLOPHOSPHAMIDE

B. M. Lynch - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

Mycophenolate mofetil

RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE RELEVANCE OF LUNG FUNCTION TESTS AND HIGH RESOLUTION COMPUTED TOMOGRAPHY IN A LARGE MULTI CENTRE SERIES

C. Kelly - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Idiopathic pulmonary fibrosis

N/A

PROGNOSIS OF MPO-ANCA-POSITIVE INTERSTITIAL PNEUMONIA PATIENTS FOLLOWING ACTIVE TREATMENT

T. Shoda - European League Against Rheumatism (EULAR) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Idiopathic pulmonary fibrosis

N/A

Filters

914 Abstracts